Jazz Pharmaceuticals

NASDAQ: JAZZ · Real-Time Price · USD
116.67
0.00 (0.00%)
At close: Aug 15, 2025, 3:04 PM

Jazz Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
2.41B 1.51B 881.48M 591.45M
Short-Term Investments
580M 120M 30M n/a
Long-Term Investments
n/a 4.7M 5.5M 12.03M
Other Long-Term Assets
123.97M 69.24M 58.89M 40.81M
Receivables
716.76M 705.79M 651.49M 563.36M
Inventory
480.44M 597.04M 714.06M 1.07B
Other Current Assets
261.54M 320.81M 267.19M 252.39M
Total Current Assets
4.63B 3.44B 2.61B 2.61B
Property-Plant & Equipment
227M 234.99M 301.38M 343.42M
Goodwill & Intangibles
6.47B 7.17B 7.49B 8.98B
Total Long-Term Assets
7.38B 7.96B 8.23B 9.69B
Total Assets
12.01B 11.39B 10.84B 12.3B
Account Payables
77.87M 102.75M 90.76M 100.3M
Deferred Revenue
n/a n/a 463K 2.09M
Short-Term Debt
31M 604.95M 31M 31M
Other Current Liabilities
896.17M 142.32M 644.07M 491.67M
Total Current Liabilities
1.04B 1.54B 933.19M 809.3M
Long-Term Debt
6.08B 5.11B 5.69B 6.02B
Other Long-Term Liabilities
86.61M 99.71M 106.81M 117M
Total Long-Term Liabilities
6.88B 6.12B 6.82B 7.52B
Total Liabilities
7.92B 7.66B 7.75B 8.33B
Total Debt
6.16B 5.79B 5.8B 6.14B
Common Stock
6K 61K 61K 61K
Retained Earnings
1.13B 878.66M 733.59M 830.23M
Comprehensive Income
-947.67M -842.15M -1.13B -400.36M
Shareholders Equity
4.09B 3.74B 3.09B 3.97B
Total Investments
580M 124.7M 35.5M 12.03M